Chronic Pain: Best Practices in Interdisciplinary Multimodal Management
Sponsored by Asante Communications, LLC
This activity is supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC. and Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
This activity is certified for credit.
Accrediting Provider
University of Medicine & Dentistry of New Jersey (UMDNJ)
Purdue University of College Pharmacy
Date
Thursday, September 8, 2011
Start Time
12:00 pm
End Time
1:30 pm
Room
Brera Ballroom
Level 4
Learning Objectives
After completing this activity, participants should be better able to:
- Employ mechanism-based pharmacotherapy for patients with common chronic pain syndromes, such as subacute and chronic low back pain and osteoarthritis
- Evaluate the clinical profiles of current and emerging pharmacologic agents based in part on pharmacokinetic and pharmacodynamic profiles, analgesic effectiveness, and treatment-related risks and side effects
- Educate patients about the biopsychosocial nature of pain and the effectiveness of mechanism-based therapies, behavioral skill sets, and transparent dialogue with their healthcare team and caregivers
- Integrate mechanism-based pharmacotherapy with nonpharmacologic therapies based, in part, on the biopsychosocial factors that shape the intensity, severity, chronicity, and adverse functional consequences of subacute and chronic pain syndromes
Faculty
Charles Argoff, MD
Michael Brennan, MD
Paul Doghramji, MD, FAAFP
Douglas Schottenstein, MD
Web site
www.pain2011showcase.com
Contact Name
Christina Santiago
Contact Phone
646-253-0894
- Pathophysiology of Pain: Mechanisms and Manifestations
- Responsible Opioid Prescribing in the Era of REMS
- Risk Mitigation in Reality: Best Practices from a Transmucosal Fentanyl REMS
- Persistent and Breakthrough Cancer Pain
- Chronic Pain: Best Practices in Interdisciplinary Multimodal Management
